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Synchrony of the mammalian circadian clock is
achieved by complex transcriptional and transla-
tional feedback loops centered on the BMAL1:
CLOCK heterodimer. Modulation of circadian feed-
back loops is essential for maintaining rhythmicity,
yet the role of transcriptional coactivators in driving
BMAL1:CLOCK transcriptional networks is largely
unexplored. Here, we show diurnal hepatic steroid
receptor coactivator 2 (SRC-2) recruitment to the
genome that extensively overlaps with the BMAL1
cistrome during the light phase, targeting genes
that enrich for circadian and metabolic processes.
Notably, SRC-2 ablation impairs wheel-running
behavior, alters circadian gene expression in several
peripheral tissues, alters the rhythmicity of the hepat-
ic metabolome, and deregulates the synchronization
of cell-autonomous metabolites. We identify SRC-2
as a potent coregulator of BMAL1:CLOCK and find
that SRC-2 targets itself with BMAL1:CLOCK in a
feedforward loop. Collectively, our data suggest
that SRC-2 is a transcriptional coactivator of the
BMAL1:CLOCK oscillators and establish SRC-2 as
a critical positive regulator of the mammalian circa-
dian clock.INTRODUCTION
Most physiological systems have an intrinsic rhythm centered on
diurnal light and feeding cycles. The central mammalian pace-
maker located within the hypothalamic suprachiasmatic nuclei
(SCN) coordinates this rhythmicity with the peripheral tissues,Csynchronizing whole-body physiology. While the SCN can
generate endogenous circadian rhythms, exogenous environ-
mental cues, such as light and temperature, help tomaintain pre-
cise synchronization of physiology with environmental changes.
Disruptions in diurnal cycling are associated with increased
risk for cardiovascular diseases, cancer, and several metabolic
derangements (Bass and Takahashi, 2010; Takahashi et al.,
2008). Molecularly, a core network of genes is responsible for
circadian oscillation arising from the heterodimerization of the
basic helix-loop-helix (bHLH) transcription factors Brain and
Muscle ARNT-Like 1 (BMAL1, ARNTL) and Circadian Locomotor
Output Cycles Kaput (CLOCK). Collectively, these transcription
factors drive circadian gene expression through a common
mechanism of transcriptional and translational feedback loops
(Asher and Schibler, 2011). Autoregulatory feedback loops are
formed by BMAL1:CLOCK binding to E box elements in pro-
moter regions of Period (Per1/2) and Cryptochrome (Cry1/2),
whose products then inhibit BMAL1:CLOCK activity. Another
ancillary feedback loop involving the nuclear receptors (NRs) is
formed by BMAL1:CLOCK governing the expression of Retinoic
Acid Receptor-Related Orphan Receptor (ROR), Rev-erba
(Nr1d1), and Rev-erbb (Nr1d2) expression. ROR activates
Bmal1 transcription, and Rev-erba/b proteins subsequently
repress Bmal1 (Akashi and Takumi, 2005; Asher and Schibler,
2011; Bugge et al., 2012; Cho et al., 2012; Preitner et al., 2002;
Sato et al., 2004; Ueda et al., 2002). Together, these feedback
loops are thought to be sufficient for controlling gene expression
to maintain the daily rhythmicity of most biological processes.
Oscillators in peripheral tissues (e.g., the liver) also have
endogenous cycling coordinated by the central clock, but can
be modulated in a tissue-specific manner by other cues, such
as steroid hormones and nutrient availability. Circadian rhythm
in peripheral tissues is intricately linked to metabolism, given
that peripheral clock synchrony can be altered through meta-
bolic cues and that perturbations are known to result in disrup-
tion of general energy homeostasis, glucose regulation, fattyell Reports 6, 633–645, February 27, 2014 ª2014 The Authors 633
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Figure 1. Analysis of Mouse Hepatic SRC-2 Cistromes at ZT4 and ZT18
(A) Venn diagram comparing SRC-2 ChIP-seq intervals from murine livers at ZT4 and ZT18.
(B) Peak intensities of the overlapping binding sites plotted as log2 of SRC-2 (ZT4) over SRC-2 (ZT18) against the number of ChIP peaks (i) and in bar graph
form (ii); ***p < 0.001. Data are graphed as the mean ± SEM.
(C) Comparative DAVID gene functional analyses for select enriched annotations of SRC-2 ZT4 and ZT18 targets.
(D) Top enriched SeqPos motifs common to ZT4/ZT18 SRC-2 binding regions, grouped by DNA binding domains of transcription factors.
(E) hd-qPCR expression of SRC-2 in WAT, BAT, heart, skeletal muscle, and liver in entrainedWTmale mice (n = 5 each) in light and dark phases. Data are graphed
as the mean ± SEM. *p < 0.05.
(legend continued on next page)
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acid metabolism, and feeding behavior (Asher and Schibler,
2011; Bass and Takahashi, 2010). Specifically, disruption of
the core clock component, BMAL1, impairs glucose homeosta-
sis, increases insulin sensitivity, and decreases whole-body
adiposity after 20weeks of age (Hatanaka et al., 2010; Kondratov
et al., 2006; Rudic et al., 2004). Similarly, disruption of the heter-
odimeric partner of BMAL1, CLOCK, also leads to impaired
glucose tolerance, increased adiposity in the CLOCK mutant,
hepatic steatosis, and a broad disruption of the hepatic metab-
olome (Eckel-Mahan et al., 2012; Fustin et al., 2012; Marcheva
et al., 2010; Rudic et al., 2004). Taken together with hepatic
genome-wide localization of BMAL1 and CLOCK targets, these
observations demonstrate that primary circadian transcription
factors are heavily involved in the regulation of hepatic meta-
bolism (Hatanaka et al., 2010; Kondratov et al., 2006; Rudic
et al., 2004). Just as core transcriptional clock components
can regulate metabolism, many hepatic metabolic transcription
factors, such as the NRs ERR, PPARa, Rev-erba/b, and ROR,
have also been identified as transcriptional mediators of clock
targets (Akashi and Takumi, 2005; Asher and Schibler, 2011;
Bugge et al., 2012; Cho et al., 2012; Preitner et al., 2002; Sato
et al., 2004; Ueda et al., 2002).
Similar crosstalk between circadian rhythm and metabolic
transcriptional regulation is coordinated through the activity of
transcriptional coregulators. Coregulators are utilized by NRs
and other transcription factors to dynamically regulate gene
transcription. In general, modulation of transcription factor
activity is achieved by corepressors silencing and coactivators
enhancing gene expression. As such, coregulators have broad
effects on target gene expression. For example, in addition to
their known role as circadian corepressors for BMAL1:CLOCK,
Per2 and Cry1 have also been reported to function as corepres-
sors for the NRs Rev-erba andGR, respectively, to facilitate tem-
poral cellular activity (Lamia et al., 2011; Schmutz et al., 2010).
Per2 and Cry1 repression of NRs is achieved through the interac-
tion of their LXXLL motifs with the NRs (Lamia et al., 2011;
Schmutz et al., 2010). The LXXLL motif is common among NR
coregulators, including the p160 family of Steroid Receptor Co-
activators (SRCs). As with many other coregulators, loss of an
SRC has profound and diverse physiological effects, ranging
from increased tumorigenic potential through altered cell-cycle
control to altered energy homeostasis through disruption of
keymetabolic processes. Specifically, our lab has identified Ste-
roid Receptor Coactivator-2 (SRC-2, NCOA2, GRIP1) as an
essential modulator of hepatic metabolism (Chopra et al.,
2008, 2011). SRC-2 serves as a critical mediator of organism-
wide energy homeostasis by regulating glucose release under
fasting conditions (Chopra et al., 2008). Loss of SRC-2 is also
associated with increased insulin sensitivity (Picard et al.,
2002), and decreased adiposity (Hartig et al., 2011). Additionally,
the activity of SRC-2 has also been shown to be directly regu-
lated by AMP-activated protein kinase (AMPK), a key metabolic
rheostat and an important sensor in circadian rhythm (Lamia(F) Representative immunoblot of liver SRC-2 in entrained WT mice at ZT2, ZT6,
(G) Validation of 24 hr circadian recruitment of SRC-2 to the Esrra promoter in liver
and ZT22.
(H) Validation of 24 hr circadian recruitment of SRC-2 to the Esrra promoter in liver
Cet al., 2009; Um et al., 2011). AMPK activates SRC-2 as a coac-
tivator in bile acid secretion, which is necessary for fat absorp-
tion from the gut (Chopra et al., 2011).
Given the broad metabolic impact of SRC-2, we sought to
understand the previously unknown temporal metabolic effects
of SRC-2 on the hepatic cistrome and metabolome. Provided
with mounting evidence that metabolism and circadian rhythm
are interlinked processes, and existing knowledge about
the effects exerted by coactivators on transcription factors in
diverse processes and tissues, we investigated the temporal
role of SRC-2 through cistromic analysis of SRC-2 in the liver
at two time points of the diurnal cycle. In this article, we demon-
strate that SRC-2 shows preferential binding during the light
phase of the circadian cycle. Additionally, we find that SRC-2
expression is rhythmic in accordance with its cistromic occu-
pancy. Running-wheel experiments also reveal that loss of
SRC-2 severely alters diurnal behavioral rhythmicity. In further
exploring the temporal effects of SRC-2 on gene expression,
we find that loss of SRC-2 disrupts not only a cassette of
metabolic genes but also core components of the clock across
several tissues, including the liver, brown adipose tissue (BAT),
white adipose tissue (WAT), heart, and skeletal muscle. Like-
wise, loss of SRC-2 disrupts hepatic and cell-autonomous
metabolite rhythmicity. Taken together, these findings suggest
that SRC-2 is a transcriptional coactivator for BMAL1:CLOCK
in the liver that couples metabolic gene expression with proper
maintenance of the hepatic peripheral clock.
RESULTS
Differential Recruitment of SRC-2 to the Hepatic
Cistrome
To better understand the temporal functions of SRC-2 in coordi-
nating energy homeostasis, we analyzed its hepatic chromatin
occupancy during two phases of the murine diurnal cycle,
zeitgeber time 4 (ZT4) in the light phase and ZT18 in the dark
phase, using chromatin immunoprecipitation followed by deep
sequencing (ChIP-seq). We found an increase in total binding
sites for SRC-2 at ZT4 (22,638) compared with ZT18 (14,376),
but with extensive overlap (78% of ZT18) between the two
ZTs (Figure 1A). Analysis of the common binding sites revealed
that SRC-2 bound more strongly at ZT4 than at ZT18, as indi-
cated by an increase in SRC-2 peak intensity (Figure 1Bi) as
well as an increase in the average number of peaks (Figure 1Bii).
In accordance with a role for SRC-2 in directly controlling gene
expression, SRC-2 binding sites at both ZT4 and ZT18 were
strongly enriched for gene-proximal regions around the tran-
scriptional start site (TSS) (Figures S1A–S1D). Further, in agree-
ment with published roles for SRC-2 in regulating hepatic
metabolism (Chopra et al., 2008, 2011), the functional processes
associated with putative SRC-2 target genes generally clustered
around major metabolic processes. In particular, ZT4 was en-
riched over ZT18 for PPAR signaling pathways, fatty acidZT10, ZT14, ZT18, and ZT22.
tissue assayed by ChIP-qPCR relative to input at ZT2, ZT6, ZT10, ZT14, ZT18,
tissue assayed by ChIP-qPCR relative to input at CT4, CT10, CT16, and CT22.
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metabolism, and ubiquitin-mediated proteolysis (Figure 1C, red
bars). Genes called from SRC-2 binding sites at ZT18 were en-
riched for a different set of metabolic processes, including xeno-
biotic, drug, and glutathione metabolism, suggesting distinct
roles for SRC-2 in the diurnal cycle (Figure 1C, blue bars). Both
the ZT4 and ZT18 genes called from SRC-2 binding sites were
equally enriched for a previously reported role of SRC-2 in pri-
mary bile acid synthesis (Chopra et al., 2011) and for circadian
rhythm. Analysis of select loci of metabolic targets shared by
both SRC-2 binding at ZT4 and ZT18 revealed increased binding
near the TSS at ZT4 of previously reported SRC-2 targets (Elovl6
and Fasn) (Jeong et al., 2006), as well as increased ZT4 peaks at
new SRC-2 targets, including NRs (Nr0b2 and Shp) and meta-
bolic targets (Ugp2 and Cyp7a1), and a circadian target (Per1)
(Figure S1E). Interestingly, we also found SRC-2 targeting its
own locus (Ncoa2/SRC-2) (Figure S1E). DNA sequence analyses
of SRC-2 binding sites at ZT4 and ZT18 revealed the expected
enrichments for NR binding motifs (HNF4a, PPARa, RAR, and
NR5a2), and SRC-2 binding sites were also enriched for the E
box motif, which is known to bind basic helix-loop-helix proteins
such as BMAL1 and CLOCK (Figure 1D).
Given that many NRs demonstrate temporal rhythms and that
SRC-2 occupancy of the cistrome at ZT4 identifies approxi-
mately twice as many peaks as at ZT18, we explored the diurnal
expression of SRC-2 using high-density quantitative PCR (hd-
qPCR) across several key metabolic tissues (i.e., liver, BAT,
WAT, heart, skeletal muscle, and SCN; Figure S1F).We identified
tissue-specific differences in temporal SRC-2 expression, but
generally SRC-2 had higher expression during the light phase
compared with the dark phase (Figure 1E). Specifically, in liver,
SRC-2 expression was found to be significantly higher at ZT2
compared with ZT18, in line with increased SRC-2 cistromic oc-
cupancy during the light phase (Figures 1A, 1E, and S1F), which
coincided with cycling of hepatic SRC-2 protein. We observed
the highest expression of SRC-2 at ZT2 in the light phase with
an 4-fold decrease in the dark phase at ZT18 (Figure 1F).
Continuing to explore SRC-2 regulation of targets in a temporal
setting, we performed ChIP-qPCR of SRC-2 over a period of
24 hr in the liver, and found that SRC-2 bound to specific pro-
moter regions in a temporal fashion, as shown with Esrra over
24 hr in both ZT (Figure 1G) and circadian time (CT; Figure 1H)
conditions (Figure S1G).
The SRC-2 and BMAL1 Cistromes Overlap Extensively
We continued to explore a role for SRC-2 in diurnal metabolic
transcription, focusing on the role of SRC-2 in the light phase
based on the consistency of results from the ChIP-seq data,
the ChIP-qPCR of SRC-2, and light-phase expression of SRC-
2. We explored a possible relationship between the SRC-2
genomic occupancy at ZT4 and transcription factors known to
display rhythmic genomic recruitment with peak activity during
the light phase. The results from the motif analysis of the SRC-
2 cistrome (Figure 1D) led us to study the E box binding
BMAL1:CLOCK (BMAL1:NPAS2) transcriptional heterodimers.
Loss of any one component of the heterodimer results in meta-
bolic derangements similar to those found upon SRC-2 ablation
(Chopra et al., 2008, 2011). Because BMAL1 is the nonredundant
heterodimeric partner for both CLOCK and NPAS2, we overlaid636 Cell Reports 6, 633–645, February 27, 2014 ª2014 The Authorsour SRC-2 ChIP-seq data with the published mouse liver cis-
trome for BMAL1 at CT4 (Koike et al., 2012; Rey et al., 2011),
and found extensive convergence of the SRC-2 (ZT4) and
BMAL1 cistromes. Analysis of these potential targets showed
that68% of genes with BMAL1 binding sites contained at least
one SRC-2 binding site within gene promoter regions (Figure 2A).
Motif analysis revealed that the overlapping peaks between
SRC-2 (ZT4) and BMAL1 were enriched primarily for the E box,
and many SRC-2 binding sites overlapped with BMAL1 sites at
known circadian genes (Per1/2/3, Cry2, Dec1/2, DBP, Dec1/2,
Gys2, Nampt, Tef, Esrra, Ppara, Por, and Rev-erba/b) (Figures
2B and S2A), suggesting that SRC-2 may serve as a transcrip-
tional coregulator for the BMAL1:CLOCK heterodimer. Not sur-
prisingly, the functional processes associated with the genes
shared by BMAL1 and SRC-2 were highly enriched for circadian
rhythm and other known BMAL1 metabolic functions, including
glycolysis/gluconeogenesis, pyruvate and fatty acid meta-
bolism, and insulin signaling (Dufour et al., 2011; Hatanaka
et al., 2010; Rey et al., 2011; Figure 2C).
To validate the temporal cistromic occupancy of SRC-2 and
possible co-occupancy of SRC-2with BMAL1 at select circadian
target genes, we performed ChIP in mouse livers over a period of
24 hr. Peak SRC-2 recruitment to the Per1 promoter occurred at
ZT6, when BMAL1 enrichment was also at its highest (Figures 2D
and S2B). We next investigated whether SRC-2 recruitment to
the Per1 promoter was BMAL1 dependent. In Bmal1/ mice,
we found that SRC-2 recruitment at ZT6 was in fact decreased
compared with wild-type (WT) mice at ZT6, suggesting that
BMAL1 is required for SRC-2 enrichment (Figure 2E). However,
we found no significant differences in BMAL1 recruitment with
the absence of SRC-2 at the Per1 promoter at ZT6 and ZT18
in SRC-2/ mice (Figure 2F). Interestingly, hepatic BMAL1
and SRC-2 ChIP experiments showed dual recruitment on the
SRC-2 promoter (Figures S2C–S2E). Again, we found that loss
of Bmal1 impaired SRC-2 recruitment to its own promoter, but
observed no differences in BMAL1 recruitment in SRC-2/
livers (Figures S2C–S2E). Collectively, our ChIP-qPCR results
suggest that SRC-2 and BMAL1 proteins can co-occupy the
circadian target, Per1, as well as the SRC-2 promoter.
We then transiently transfected cultured cells to test SRC-2
modulation of BMAL1:CLOCK-mediated transcription on both
the Per1 and SRC-2 promoters, and found that overexpression
of SRC-2 enhanced BMAL1:CLOCK activity (Figures 2G and
S2F). To determine whether SRC-2 transcriptional coactivation
was dependent on the BMAL1:CLOCK heterodimer, we used
small interfering RNA (siRNA) to deplete Bmal1. We found that
SRC-2 coactivation of both the Per1 and SRC-2 promoters was
impaired when compared with control levels of activity (Figures
2H, S2G, and S2H). Likewise, siRNA depletion of SRC-2 alone
impaired BMAL1 activity on both the Per1 and SRC-2 promoters
(Figures 2I, S2I, and S2J). Given that SRC-2 can transactivate the
BMAL1:CLOCKheterodimer and the convergence of their hepat-
ic cistromes, we investigated a possible endogenous interaction
between SRC-2 and BMAL1:CLOCK in the liver. We found that
endogenous hepatic SRC-2 immunoprecipitates with BMAL1
at ZT6 corresponding to peak SRC-2 protein expression (Fig-
ure 2J).We recapitulated these results in cell culture, with endog-
enous SRC-2 coimmunoprecipitating with both BMAL1 and
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Figure 2. Analysis of SRC-2 Occupancy across the Hepatic Genome Shows Enrichment for Circadian Targets
(A) Venn diagram representing the unique and overlapping genes that have SRC-2 (ZT4) and BMAL1 (CT4) (Koike et al., 2012) binding sites within the extended
gene promoter region (EPR) as assayed by ChIP-seq.
(B) Circadian genes and E box sequence motif found in the SRC-2/BMAL1 overlapping portion of the data sets.
(C) Gene functional analyses of targets with shared BMAL1 and SRC-2 binding sites.
(D) Profile of 24 hr circadian recruitment of SRC-2 and BMAL1 to the Per1 promoter in liver tissue as assayed by ChIP-qPCR relative to input.
(E) Recruitment of SRC-2 to the Per1 promoter in WT and Bmal1/ mice at ZT6 and ZT18.
(F) Recruitment of BMAL1 to the Per1 promoter in WT and SRC-2/ mice at ZT6 and ZT18.
(G) Transactivation of cotransfected SRC-2, BMAL1, CLOCK, and Cry1 expression constructs on the Per1-promoter driving the luciferase gene in HepG2 cells.
Cry1 expression was used as a control to demonstrate transcriptional repression.
(H) Transactivation assays on the Per1-Luciferase promoter with SRC-2 and siBMAL1.
(I) Transactivation assays on the Per1-Luciferase promoter with BMAL1 and siSRC-2.
(J) Coimmunoprecipitations of BMAL1 with SRC-2 at ZT6 in WT mouse liver.
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Figure 3. Ablation of SRC-2 Disrupts Central Clock Rhythmicity
(A) Representative actograms of male WT and SRC-2/ (n = 6) littermate mice locomotor activity in L/D and D/D conditions.
(B) Graphical representation of locomotor activity of WT and SRC-2/ (n = 6) mice in L/D.
(C) Percentage of time WT and SRC-2/ (n = 6) mice spent running during a 12 hr light phase and 12 hr dark phase.
(D) Average tau for WT and SRC-2/ mice during D/D conditions.
(E) Diurnal food consumption during L/D conditions as measured by the Columbus Instruments Comprehensive Lab Animal Monitoring System (CLAMS) in WT
and SRC-2/ (n = 9–10) mice. Data are graphed as the mean ± SEM. *p < 0.05, **p < 0.01 versus WT mice.CLOCK (Figure S2K). We used an in vitro pull-down to determine
whether SRC-2 can directly interact with BMAL1, and found the
region of SRC-2 that contains the LXXLL amino acidmotifs (730–
1121) to be required for BMAL1 binding (Figure S2L), suggesting
that SRC-2 may interface with BMAL1 similarly to its interaction
with other NRs (Li et al., 2004; Ye et al., 2011). Overall, these
data suggest that SRC-2 can directly interact with BMAL1 and
CLOCK, and serves as a transcriptional coactivator for the
BMAL1:CLOCK heterodimer. These events may be driven by
temporal interactions with the BMAL1:CLOCK heterodimer.638 Cell Reports 6, 633–645, February 27, 2014 ª2014 The AuthorsSRC-2 Modulates Diurnal Behavior
We subsequently examined the effects of genetic SRC-2 abla-
tion on diurnal behavior by analyzing locomotor activities of
WT and SRC-2/mice in 12 hr light/12 hr dark (24 hr L/D) cycles
and in constant darkness (24 hr D/D cycles). We found that loss
of SRC-2 markedly altered circadian locomotor behaviors under
L/D entrained conditions (Figure 3A). The phenotypic spectrum
observed in SRC-2/ mice in L/D cycles ranged from phase-
advanced behavior manifested by running activity during the
light phase (SRC-2/, Figure 3A, left panel) to complete
arrhythmic behavior (SRC-2/, Figure 3A, right panel). The
abnormal behavior pattern for mutant mice persisted in the
absence of environmental light cues (24 hr D/D cycles). Locomo-
tor activity quantified during L/D cycles revealed that SRC-2/
mice exhibit a bimodal running pattern, with the first minor
peak of activity occurring late in the light phase and the second,
major peak of activity occurring in the dark phase (Figure 3B).
Interestingly, the amplitude of the major activity peak was signif-
icantly dampened in SRC-2/ mice (Figure 3C). Therefore, un-
like WT mice, in which >90% of activity occurred in the dark
phase, the running activity of SRC-2/ mice was scattered,
with 40% in the light phase and only 60% in the dark phase (Fig-
ure 3C). Although SRC-2 ablation did not significantly affect the
average period length for themutant population, as shown by the
near-equivalent mean tau values for WT and SRC-2/ mice, it
produced considerable daily variation in period length within
individual SRC-2/ mice (Figures 3D and S3A–S3C). Together,
the above observations suggest that loss of SRC-2 disrupts the
central clock, thereby altering L/D activity amplitudes.
Circadian clock alterations are thought to promote several
metabolic pathophysiologies.Using thediscoveredcircadiande-
fects inSRC-2/mice,we investigateddiurnal feedingbehavior.
In accordancewithpublisheddata (Chopra et al., 2008),we found
no difference in total food consumption between WT and SRC-
2/mice over 24 hr (data not shown). However, the peak feeding
behavior of SRC-2/ mice was shifted approximately 85 min
before that of WT mice, mirroring the phase-advanced behavior
seen in the actograms (Figure 3E). As in other tissues, we found
cycling of SRC-2 expression in the SCN, with peak expression
mirroring that in the liver (Figures S1F and S4A). To remove any
effects of external light cues, we examined circadian gene
expression during free-running conditions (D/D) and found signif-
icant differences in core circadian gene expression (Bmal1,Per1,
and Cry1) primarily at CT22 and CT4 in the SRC-2/ mice (Fig-
ure S3D). These results suggest that SRC-2 functions within the
SCN to help maintain central clock oscillation.
Together, our data demonstrate that loss of SRC-2 results in
phase-advanced phenotypes in locomotor activity and possibly
in feeding behavior, and suggest a more intricate interplay of
SRC-2 in coordination of circadian rhythm and metabolism.
SRC-2 Regulates Peripheral Clock Rhythmicity
Interactions between the master and peripheral clocks are
necessary to maintain processes such as blood pressure, meta-
bolism, digestion, and endocrine signaling (Mohawk et al., 2012;
Ptitsyn et al., 2006). The strong behavioral defects observed with
SRC-2 ablation in the running wheels led us to investigate the
role of SRC-2 in several peripheral clocks.
We used hd-qPCR to examine the systemic effect of SRC-2
ablation in the liver, heart, skeletal muscle, BAT, and WAT. We
profiled 48 genes specifically chosen for sharing SRC-2 and
BMAL1 binding sites in the ChIP-seq data sets, focusing on
core circadian genes, NRs involved in coordinating metabolic
cassettes, and several metabolic targets (Table S1). SRC-2
deletion significantly altered temporal expression patterns for
all peripheral clocks, but in a tissue-specific manner (Figure 4A).
We observed the most gene changes in the liver, with altered
profiles found primarily at ZT2 and ZT22. Within the liver, alteredCexpression between WT and SRC-2/mice was found in many
circadian genes, including Bmal1, Clock, Per1/2, Npas2, and
Cry1, as well as the clock-stabilizing genes Por, Dec1, and
Dbp (Figure 4B). We also found profile changes in genes encod-
ing the NRs (Shp [Nr0b2], Esrra, Rev-erbb, andHnf4a; Figure 4C)
and several metabolic targets (Gys2, Elovl6, Ldha, and Fads2)
(Figure 4D). We also investigated the effects of SRC-2 loss on
circadian gene expression in WT and SRC-2 liver-specific
knockout mice (LKO), and found that with SRC-2 absent from
the liver only and an intact SCN, there was still aberrant circadian
cycling (Figure S4A). Most similar to the liver was BAT, where
again more gene changes occurred at ZT2-ZT6 and ZT18–
ZT22, with changes in circadian genes (Por, Per1, and Cry2)
and several metabolic genes (Dgat2 and Pnpla2; Figure S4B).
In general, all tissues analyzed showed changes in the temporal
expression of circadian oscillators. Similar to the metabolic pro-
cesses revealed by hepatic ChIP-seq, we found that WAT, heart,
and skeletal muscle also showed changes in genes involved in
glucose metabolism (Pdk4 and Pdk1), lipid synthesis (Fads2,
Elovl6, and Dgat2), and pyruvate metabolism (Pdk4 and Pdk1;
Figures S4B–S4E). Overall, the fewest changes were observed
in skeletal muscle and heart compared with the other tissues,
and interestingly, although the heart and skeletal muscle shared
similar metabolic targets, we found that the changes in these
tissues occurred at different phases (ZT6 in the skeletal muscle
and ZT 18 in the heart; Figure 4A).
Since many of the SRC-2 targets we identified have reported
functions in metabolism, we next examined whether ablation of
SRC-2 could affect the oscillations of circulating plasma metab-
olites. Colorimetric-based assays revealed a significant in-
crease at ZT10 in SRC-2/ mice in plasma nonesterified fatty
acids (NEFA), a significant increase in SRC-2/ triglycerides
at ZT18, and overall no change in cholesterol concentrations be-
tweenSRC-2/ andWTmice (Figure 4E). Altered diurnal cycling
of plasma metabolites is likely a consequence of temporal
disruption of metabolic genes targeted by SRC-2, as we have
shown by hd-qPCR.
SRC-2 Ablation Alters Hepatic Metabolites
Subsequently, we went back to study the temporal regulation of
metabolites in the liver of WT and SRC-2/ mice. Our lab has
previously identified that loss of SRC-2 has whole-body conse-
quences for metabolite profiles in fed and fasted mice, but sur-
prisingly few changes were found in the SRC-2/ liver (York
et al., 2013). Recent data suggest that in addition to the rhyth-
micity observed in the transcriptome, the metabolome is also
subject to circadian regulation, as shown in the liver-specific
Bmal1/ mouse and Clock/ mouse (Eckel-Mahan et al.,
2012; Fustin et al., 2012). Therefore, we analyzed hepatic metab-
olomics over the diurnal cycle in WT and SRC-2/ mice for
metabolites in lipid/fatty acid pathways, glycolysis/gluconeogen-
esis, energy metabolism in the tricarboxylic acid cycle (TCA) cy-
cle, and nucleotide synthesis. We again observed that SRC-2/
mice showed a temporal effect with deregulation of cycling me-
tabolites (Figures 5A, S5A, and S5B). Most of the changes
observed occurred at ZT2 and ZT10, which is in agreement
with our initial ChIP-seq and gene-expression studies.More spe-
cifically, the metabolite changes we observed were found to beell Reports 6, 633–645, February 27, 2014 ª2014 The Authors 639
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Figure 4. Loss of SRC-2 Results in Aberrant Peripheral Circadian Clock Gene Expression in the Liver
(A) Graphical summary representation of the gene changes observed at different ZTs in core metabolic tissues using the hd-qPCR array.
(B) hd-qPCR analysis of temporal circadian gene expression in liver from entrained WT and SRC-2/ (n = 3–5) mice.
(C) hd-qPCR analysis of NR gene expression.
(D) hd-qPCR analysis of metabolic genes. The maximal value from each analyzed gene was normalized to one.
(E) Plasma analysis of NEFAs, triglycerides, and cholesterol at ZT2, ZT10, and ZT18 fromWT and SRC-2/ (n = 3–5) mice. Data are graphed as themean ± SEM.
*p < 0.05, **p < 0.01, ***p < 0.001 versus WT mice.
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Figure 5. Loss of SRC-2 Disrupts the Rhythmicity of the Hepatic Metabolome
(A) Heatmap of the metabolites analyzed in WT and SRC-2/ mice at ZT10.
(B) Functional analysis of significant metabolites altered at ZT10.
(C) Selected metabolite changes in WT and SRC-2/mice at ZT2, ZT10, and ZT18 (n = 3–5). Data are graphed as the mean ± SEM. *p < 0.05 versus WT mice.enriched in processes associated with carbon metabolism and
glycolysis/gluconeogenesis (Figure 5B). These findings support
functional correlates with the processes predicted from the
overlap of the SRC-2 and BMAL1 cistromes (Figure 2B). Further,
analysis of selected metabolites within the glycolysis/gluconeo-
genesis and the TCA cycle, including glucose, glucose-6-phos-
phate/fructose-6-phosphate (G6P/F6P), ketoglutarate, andCpyruvate, showed that loss of SRC-2 alters the fluxof hepaticme-
tabolites in a time-dependent manner (Figure 5C).
SRC-2 Regulation of Metabolic Rhythmicity Is Cell
Autonomous
Wecompared systemic regulationversuscell-autonomousmeta-
bolic regulation with loss of SRC-2 by using a cell-autonomousell Reports 6, 633–645, February 27, 2014 ª2014 The Authors 641
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Figure 6. SRC-2 Deletion Significantly Disrupts the Cell-Autonomous Clock
(A) qPCR analysis of circadian gene expression in synchronized MEFs isolated from SRC-2flox/flox mice infected with either Ad-GFP or Ad-Cre-GFP. Data
represent triplicates at each time point for maximal gene expression of Ad-GFP normalized to one, graphed as the mean ± SEM. *p < 0.05 versus WT.
(B) Heatmap of metabolic phenotypemicroarray of carbonmetabolism in synchronized MEFs isolated from SRC-2flox/flox mice infected with either Ad-GFP or Ad-
Cre-GFP at Hr10 (n = 3). Data are graphed as the mean ± SEM. *p < 0.05 versus WT mice.
(C) Schematic representation of the role of SRC-2 as a BMAL1:CLOCK transcriptional coactivator for core clock genes.system to remove any associated tissue-specific endogenous
circadian influences. We isolated and immortalized mouse em-
bryonicfibroblasts (MEFs) fromSRC-2flox/flox animals (FigureS6A)
and then infected thecellswitheitherGFPadenovirus (Ad-GFP)or
Cre-recombinase-GFP adenovirus (Ad-Cre-GFP). With SRC-2
knockout in MEFs, we still observed altered gene expression of
several circadian genes, including Bmal1, Per1, and Cry1, in Ad-
Cre-GFP SRC-2flox/flox MEFs (Figure 6A). Similar to the results
from qPCR in cycling MEFs and liver (Figure 4B), we saw that
depletion of SRC-2 in MEFs reduced the amplitude of Per2
(Figure S6B). Next, we compared primary hepatocytes from WT
and SRC-2/ mice with the circadian rhythm data obtained
from whole-liver physiology. Consistent with the tissue-specific
data, expression of core circadian genes was also altered in
SRC-2/ hepatocytes (Figure S6C).
Next, we explored the cell-autonomous role of SRC-2 in the
hepatic metabolic phenotypes seen in the SRC-2/ mice. In642 Cell Reports 6, 633–645, February 27, 2014 ª2014 The Authorsline with the liver metabolome, quantitative analysis showed
that SRC-2 deletion alters themetabolic phenotype of cells, spe-
cifically highlighting differences in carbohydrate usage.We found
differences in carbonmetabolism between Ad-GFP and Ad-Cre-
GFP SRC-2flox/flox MEFs enriching in glycolysis and gluconeo-
genesis pathways (Table S2). Kinetic analysis of metabolite
uptake and utilization revealed that SRC-2 ablation imparts
stronger effects at hour 10 (Hr10; Figure 6B) than at Hr2 or Hr18
(Figures S6D and S6E), suggesting that SRC-2 plays a pivotal
role in cell-autonomous metabolic regulation. Collectively, these
data indicate that SRC-2 is important for maintaining metabolic
rhythmicity in a cell-autonomous manner.
Our model proposes that SRC-2 serves a transcriptional
coactivator of the BMAL1:CLOCK heterodimer during the light
phase of the circadian clock. Notably, SRC-2 also targets
its own promoter in a feed-forward loop as a BMAL1:CLOCK
circadian target (Figure 6C).
DISCUSSION
Our collective analysis of SRC-2 strongly indicates that it plays
a systemic role in coordinating circadian and metabolic gene
expression in peripheral clockworks. Circadian control depends
largely on the coordinated rhythmicity of central and peripheral
clocks, which at the molecular level are driven by the BMAL1:
CLOCK heterodimer. We have demonstrated that SRC-2
is a transcriptional coregulator of BMAL1:CLOCK, and loss of
SRC-2 disrupts diurnal rhythms stemming from the central
clock, as revealed by abnormal running-wheel behaviors down-
stream of the transcriptome and metabolome in the liver periph-
eral clock. Additionally, we investigated the relevance of the
overlapping SRC-2 and BMAL1 targets in human epidemiology
through the HuGE Navigator, and found enrichments in human
diseases such as glycogen storage disease type 1 and Von
Gierke’s disease (Table S3; Chopra et al., 2008), as well as
several mental disorders in which we previously observed neuro-
behavioral defects in the SCR-2/mice (Stashi et al., 2013). We
also found other possible disease associations for SRC-2,
including thrombosis, premature aging, and sleep disorders per-
taining to circadian rhythm, all of which BMAL1 is known be
associated with (Bunger et al., 2000; Kondratov et al., 2006; So-
manath et al., 2011).
We have also demonstrated that SRC2 deletion disrupts
metabolic rhythmicity at the cell-autonomous level. It is surpris-
ing that SRC-2 ablation has such a dramatic effect on the central
circadian clock and peripheral clocks, given its previously
unidentified role as a coregulator in circadian regulation.
Coactivators and corepressors are well recognized to assist
in circadian transcriptional regulation by either amplifying or
suppressing gene expression. Other coregulators have been
described to play a role in circadian rhythm as well, including
NCoR with HDAC3, PGC1-a, RIP140, JARID1a, MAP1a,
TRAP150, and several others that influence the activities of
both NRs and BMAL1:CLOCK (Curtis et al., 2004; DiTacchio
et al., 2011; Feng et al., 2011; Lande-Diner et al., 2013; Li
et al., 2013; Liu et al., 2007; Poliandri et al., 2011). We believe
that the ability of SRC-2 to positively regulate circadian gene
expression is largely achieved by coactivation of BMAL1:CLOCK
and by SRC-2 targeting its own promoter, possibly to strengthen
gene expression in a feed-forward loop. This suggests that
SRC-2 serves a physiological function in modulating the
dynamic multiparametric metabolic and circadian responses of
living systems (Figure 6C).
The link between metabolism and circadian regulation is un-
disputed. Metabolic deregulations and associated pathologies
are seen in other circadian mutant mouse models. For example,
analogously to SRC-2/ mice, the Bmal1 mutant not only has
gross central and peripheral clock disruptions but also shows
impaired gluconeogenesis, increased insulin sensitivity, infer-
tility, and defects in adipose accretion (Chopra et al., 2008,
2011; Hatanaka et al., 2010; Kondratov et al., 2006; Picard
et al., 2002; Rudic et al., 2004). Our data reveal that SRC-2 has
a surprisingly strong circadian phenotype and serves as an
important coregulator for the molecular clock by positively stim-
ulating the transcriptional activity of BMAL1:CLOCK. In addition,
SRC-2 also may function with AMPK or other energy-sensingCmolecules to help intercalate circadian and metabolic transcrip-
tional regulation (Lamia et al., 2009; Um et al., 2011).
Our studies highlight SRC-2 as a potent transcriptional coac-
tivator of BMAL1:CLOCK, providing an integral link between the
previously known physiological importance of SRC-2 and its
newly appreciated role in circadian rhythm. Given the numerous
metabolic roles of SRC-2 and its known roles in reproduction
and now circadian rhythm, this work further solidifies the sys-
temic importance of SRC-2 and aims to provide a mechanism
to link these processes. In this way, SRC-2 has evolved as a
master integrator of energy accretion, energy storage, reproduc-
tion, cellular proliferation, and (as shown herein) the circadian
clock (O’Donnell et al., 2012; Chopra et al., 2008, 2011; Gehin
et al., 2002; Hartig et al., 2011; Picard et al., 2002). The evolu-
tionary advantages of a master regulator for these interrelated
physiological processes are evident. Through loss of SRC-2
alone, we have shown a disruption of total physiology, and
thus conclude that SRC-2 may play a much greater role in the
regulatory axis of energy, circadian rhythm, and reproduction
than previously thought.
EXPERIMENTAL PROCEDURES
Animals
The generation of SRC-2/, SRC-2flox/flox, SRC-2 LKO, and Bmal1/ mice
was described previously (Bunger et al., 2000; Chopra et al., 2011; Gehin
et al., 2002). Congenic WT and SRC-2/ male littermate mice (ages 10–
20 weeks) were used for all studies, except for generation of MEFs. All mice
were entrained under strict temperature control and ad libitum food (normal
chow, 2920X; Teklad Global) and water access under 12 hr L/D conditions
for at least 2 weeks prior to tissue collection for RNA and protein. The Animal
Care and Research Committee at Baylor College of Medicine approved all
animal studies.
ChIP-Seq
ChIP-seq was performed by Active Motif on C57BL/6J WT liver lysates
sacrificed at ZT4 and ZT18, and SRC-2/ liver lysate at ZT4 using the mouse
SRC-2 antibody 346A (Bethyl Laboratories). Approximately 24 million reads
identified by Illumina’s Genome Analyzer 2 were mapped to the mouse
genome (Build37.1/mm9) using the ELAND software. Only the sequences
that uniquely mapped with no more than two mismatches in the first 28 bp
were kept and used as valid reads. Peak calling was carried out by MACS
1.3.7.1 (option: p value = 1 3 1010 and MFOLD 30) were used.
ChIP-Seq Data Analysis
Galaxy/Cistrome’s SeqPos motif tool (v1.0.0) (http://cistrome.dfci.harvard.
edu/ap/root) was utilized on the entire SRC-2 ChIP-seq interval set (20,599
intervals) for de novo (MDscan algorithm) and reference-based (Transfac,
JASPAR, pbm, and hPDI databases) sequence motif analyses, and Galaxy/
Cistrome’s implementation of the CEAS tools was used for enrichment
analyses on chromosomes and genomic annotations. DAVID (Database for
Annotation, Visualization and Integrated Discovery) Bioinformatics Resources
v6.7 (http://david.abcc.ncifcrf.gov/) was used on protein coding genes to
identify enriched biological themes. For data integration and metagenomics
data analysis, the binding sites for SRC-2 and BMAL1 (Koike et al., 2012)
were related to mouse reference gene annotations (ftp://ftp.ncbi.nlm.nih.
gov/genomes/MapView/Mus_musculus/sequence/BUILD.37.1) and formed
into a relational database system for easy querying and data sharing.
ChIP
Liver tissue was isolated and flash frozen at designated ZTs from WT or
selected knockout mice as indicated. Chromatin was isolated using the Sim-
pleChIP Enzymatic Chromatin IP Kit (Cell Signaling) and performed per theell Reports 6, 633–645, February 27, 2014 ª2014 The Authors 643
manufacturer’s suggestion. The SRC-2 (Bethyl) and BMAL1 (Abcam) anti-
bodies were used at 3 mg/ml. qPCRwas performed with gene-specific primers
and SyberGreen technology (Applied Biosystems) normalized to total input
DNA. All ChIP primer sequences are available upon request.
ACCESSION NUMBERS
The ChIP-seq data sets have been deposited in the NCBI Gene Expression
Omnibus and are accessible under accession number GSE53039.
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